welcome to the sikora lab
The Sikora Lab was launched in August 2016. With our research group focusing on invasive lobular carcinoma of the breast, we strive to create an environment where our staff and early-career researchers (ECRs; students, postdocs, and fellows) can advance both our collective research efforts and their own unique training and career development goals.
AT THE BENCH
Understand steroid hormone signaling in cancer, with a focus on response to endocrine therapy and anti-estrogen resistance in breast cancer.
Understand steroid hormone signaling mechanisms in invasive lobular carcinoma of the breast.
TOWARD THE CLINIC
Improve the outcomes of patients with hormone-dependent breast cancer and other cancers primarily affecting women.
FOR OUR RESEARCH COMMUNITY
Train productive, collaborative, and responsible members of the scientific community.
We are recruiting graduate students from these CU Anschutz PhD programs:
Biomedical Sciences Program | Cancer Biology | Pharmacology | Molecular Biology
Still in college? Contact us for undergraduate research opportunities or check out a list of programs here.
Read the Sikora Lab's recent work on estrogen receptor function in lobular carcinoma.
Featured on the August 2021 cover of Molecular Cancer Research
Lobular Breast Cancer:
Clinical Care, Patient Experience, and the Frontiers of ILC Research
Watch the video from our first outreach event to learn about the unique biology and clinical management of lobular breast cancer, and our lab's research on ILC.
Learn more about the collaborative peer group co-founded by Dr. Sikora, focused on the research and career development of scientists studying nuclear receptors.
FOLLOW US ON TWITTER
The PI: @mjsikora
The Lab: @SikoraLab